GlaxoSmithKline | GSK - Ebitda

Stock Price
1,925.00
Daily Change
48.50 2.58%
Monthly
5.74%
Yearly
37.65%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP3.18B in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
AbbVie USD 4.34B 56M Jun/2025
Alcon AG USD 654M 404M Sep/2025
Amgen USD 3.6B 147M Jun/2025
argenx SE USD 288.02M 84.53M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Bayer EUR 1.51B 1.28B Sep/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 931.26M 60.26M Sep/2025
Galapagos EUR -158.71M 177.84M Mar/2025
Genmab DKK 477M 101M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Glaxosmithkline GBP 4.75B 1.52B Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.46B 45M Jun/2025
Merck USD 8.39B 1.97B Sep/2025
Novartis USD 5.88B 290M Sep/2025
Novo Nordisk DKK 31.44B 6.84B Sep/2025
Orion EUR 135.1M 16.5M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Philips EUR 738M 9M Sep/2025
Recordati EUR 247.57M 21.38M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.03B 334M Jun/2025